Technology area: Biotechnology & Pharmaceuticals
31 pending office actions • 5 clients • 29 examiners • 22 art units • 0 of 31 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Fox Rothschild LLP - JHU has 29 pending office actions in Biotechnology & Pharmaceuticals. The profile also reports 10880 career applications, a resolved allowance rate of 81.38%, and an average of 3.36 office actions per allowance.
The historical application and outcome metrics are presented at the profile level, while the pending docket is specific to the JHU designation. Practitioners should therefore treat the allowance rate and action average as broader firm-level context rather than client-specific results. The current workload indicates active prosecution in biotechnology and pharmaceuticals.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (10%) |
| §103 only | 3 (10%) |
| §112 only | 1 (3%) |
| Double-patenting + other | 4 (13%) |
| Multi-statute (no §101) | 20 (65%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLOOP, ALLISON ELIZABETH | 2 | 63.3% | +47.6% |
| MINCHELLA, KAITLYN L | 2 | 26.4% | +21.7% |
| KENNEDY, SARAH JANE | 1 | 0.0% | +0.0% |
| MENSH, ANDREW J | 1 | 64.5% | +19.2% |
| GU, QINHUA | 1 | 76.2% | +27.1% |
| GURLEY, JAMI MICHELLE | 1 | 54.8% | +14.3% |
| BARRON, SEAN C | 1 | 52.7% | +30.4% |
| BELL, SARA ELIZABETH | 1 | 68.8% | +38.2% |
| RAYMONDA, MATTHEW HAROLD | 1 | 40.0% | +47.7% |
| CESARE, JOSEPH DAVID | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17779936 | METHODS AND COMPOSITIONS FOR ANALYSES OF CANCER | KAPUSHOC, STEPHEN THOMAS | 71d overdue |
| 18286185 | TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL | BELL, SARA ELIZABETH | 26d overdue |
| 18268893 | DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION | GRAY, JESSICA | 18d overdue |
| 16753567 | IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME | BROWE, DAVID | 17d overdue |
| 18202066 | MAP KINASE PATHWAY TARGETS FOR THE TREATMENT OF MARFAN SYNDROME | HAM, JIEUN | 15d overdue |
| 17204892 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | MINCHELLA, KAITLYN L | 5d overdue |
| 18013864 | METHODS TO GLYCOENGINEER PROTEINS | DAHLE, CHUN WU | 63d |
| 18027067 | NUCLEIC ACID DETECTION USING A NUCLEASE ACTUATOR | SALVOZA, M FRANCO G | 84d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17771772 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER | SCHLOOP, ALLISON ELIZABETH | 46d overdue |
| 18286185 | TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL | BELL, SARA ELIZABETH | 26d overdue |
| 17204892 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | MINCHELLA, KAITLYN L | 5d overdue |
| 18844364 | METHOD AND SYSTEM FOR DELIVERY OF THERAPEUTICS TO EYE | MENSH, ANDREW J | — |
| 18705720 | CONTROLLING HOMEOSTATIC REGULATORY CIRCUITRY IN HYPOTHALAMUS | GU, QINHUA | — |
| 18438286 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | GURLEY, JAMI MICHELLE | — |
| 18566519 | BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS | BARRON, SEAN C | — |
| 18280164 | NUCLEIC ACID DETECTION AND ANALYSIS SYSTEMS | SCHLOOP, ALLISON ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1683 | 4 |
| 1682 | 2 |
| 1675 | 2 |
| 1643 | 2 |
| 1641 | 2 |
| 1618 | 2 |
| 1685 | 2 |
| 3781 | 1 |
| 1633 | 1 |
| 1647 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18972277 | IN SITU NUCLEIC ACID ANALYSIS USING PROBE PAIR LIGATION | The Johns Hopkins University | KENNEDY, SARAH JANE | 1682 | §112 | Final Rejection | — | Pending | Dec 06, 2024 |
| 18844364 | METHOD AND SYSTEM FOR DELIVERY OF THERAPEUTICS TO EYE | The Johns Hopkins University | MENSH, ANDREW J | 3781 | §102§103§112 | Non-Final OA | — | Pending | Sep 05, 2024 |
| 18705720 | CONTROLLING HOMEOSTATIC REGULATORY CIRCUITRY IN HYPOTHALAMUS | The Johns Hopkins University | GU, QINHUA | 1633 | §102§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18438286 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | Johns Hopkins University | GURLEY, JAMI MICHELLE | 1647 | §102§103§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18566519 | BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS | UNIVERSITY OF WASHINGTON | BARRON, SEAN C | 1653 | §102§103 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18286185 | TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL | The Johns Hopkins University | BELL, SARA ELIZABETH | 1625 | §102§103 | Final Rejection | 26d overdue | Pending | Oct 09, 2023 |
| 18280164 | NUCLEIC ACID DETECTION AND ANALYSIS SYSTEMS | The Johns Hopkins University | SCHLOOP, ALLISON ELIZABETH | 1683 | §103§112 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18280166 | MOLECULAR INDEXING OF PROTEINS BY SELF ASSEMBLY (MIPSA) FOR EFFICIENT PROTEOMIC INVESTIGATIONS | The Johns Hopkins University | RAYMONDA, MATTHEW HAROLD | 1684 | §103§112DP | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18278998 | THERAPEUTIC COMPOSITIONS AND METHODS | Johns Hopkins University | CESARE, JOSEPH DAVID | 1675 | §102§103§112 | Non-Final OA | — | Pending | Aug 25, 2023 |
| 18223331 | MULTI-IMAGER COMPATIBLE ROBOT FOR IMAGE-GUIDED INTERVENTIONS AND FULLY AUTOMATED BRACHYTHERAPY SEED | The Johns Hopkins University | HONRATH, MARC D | 3791 | §103§112 | Final Rejection | — | Pending | Jul 18, 2023 |
| 18217857 | BACTERIAL BIOFILMS AND CANCER | National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government | GANGLE, BRIAN J | 1645 | §102§103§112Other | Non-Final OA | — | Pending | Jul 03, 2023 |
| 18268893 | DETECTION OF LUNG CANCER USING CELL-FREE DNA FRAGMENTATION | The Johns Hopkins University | GRAY, JESSICA | 1682 | §101§103§112Other | Final Rejection | 18d overdue | Pending | Jun 21, 2023 |
| 18209992 | COMPOSITIONS AND METHODS OF RNA ANALYSIS | The Johns Hopkins University | POHNERT, STEVEN C | 1683 | §103§112 | Final Rejection | — | Pending | Jun 14, 2023 |
| 18202066 | MAP KINASE PATHWAY TARGETS FOR THE TREATMENT OF MARFAN SYNDROME | The Johns Hopkins University | HAM, JIEUN | 1643 | §102§103§112 | Final Rejection | 15d overdue | Pending | May 25, 2023 |
| 18247144 | INTEGRATED PROTEOMIC BIOMARKERS FOR THE DETECTION OF AGGRESSIVE PROSTATE CANCER | The Johns Hopkins University | DENT, ALANA HARRIS | 1643 | §103§112 | Non-Final OA | — | Pending | Mar 29, 2023 |
| 18027067 | NUCLEIC ACID DETECTION USING A NUCLEASE ACTUATOR | The Johns Hopkins University | SALVOZA, M FRANCO G | 1672 | §103§112 | Non-Final OA | 84d | Pending | Mar 17, 2023 |
| 18015684 | COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY | The Johns Hopkins University | ROONEY, NORA MAUREEN | 1641 | §102§103 | Non-Final OA | — | Pending | Jan 11, 2023 |
| 18013864 | METHODS TO GLYCOENGINEER PROTEINS | The Johns Hopkins University | DAHLE, CHUN WU | 1641 | §102§112 | Final Rejection | 63d | Pending | Dec 29, 2022 |
| 17873980 | IN SITU FORMING COMPOSITE MATERIAL FOR TISSUE RESTORATION | The Johns Hopkins University | JONES, DAMERON LEVEST | 1618 | §103§112Other | Non-Final OA | — | Pending | Jul 26, 2022 |
| 17842893 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | The Johns Hopkins University | MINCHELLA, KAITLYN L | 1685 | §103Other | Final Rejection | — | Pending | Jun 17, 2022 |
| 17779936 | METHODS AND COMPOSITIONS FOR ANALYSES OF CANCER | Stichting VU | KAPUSHOC, STEPHEN THOMAS | 1683 | §103§112 | Final Rejection | 71d overdue | Pending | May 25, 2022 |
| 17771772 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ESOPHAGEAL CANCER | The Johns Hopkins University | SCHLOOP, ALLISON ELIZABETH | 1683 | §103DP | Final Rejection | 46d overdue | Pending | Apr 25, 2022 |
| 17767389 | HIGHLY MULTIPLEXED DETECTION OF NUCLEIC ACIDS | The Johns Hopkins University | ALAM, DANYAL HASSAN | 1600 | §103§112DP | Final Rejection | — | Pending | Apr 07, 2022 |
| 17630104 | METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV) | The Johns Hopkins University | OGUNTADE, ELIZABETH BISOLA | 1677 | §101§103§112DP | Non-Final OA | — | Pending | Jan 25, 2022 |
| 17598690 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | The Johns Hopkins University | LU, CHENG | 1642 | §102§103§112DP | Non-Final OA | — | Pending | Sep 27, 2021 |
| 17438874 | STICKY PARTICLES FOR EFFICIENT IMAGING | The Johns Hopkins University | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | — | Pending | Sep 13, 2021 |
| 17204892 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | The Johns Hopkins University | MINCHELLA, KAITLYN L | 1685 | §101§103Other | Final Rejection | 5d overdue | Pending | Mar 17, 2021 |
| 17180696 | NAÏVE HUMAN EMBRYONIC VASCULAR PROGENITOR CELLS AND METHODS OF TREATMENT | The Johns Hopkins University | GONZALES, JOSEPHINE MARIA | 1638 | §103§112Other | Final Rejection | — | Pending | Feb 19, 2021 |
| 17139665 | COMPOSITIONS AND METHODS TO ACCELERATE RESOLUTION OF ACUTE LUNG INFLAMMATION | The Johns Hopkins University | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112Other | Non-Final OA | — | Pending | Dec 31, 2020 |
| 16753567 | IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME | The Johns Hopkins University | BROWE, DAVID | 1617 | §103§112Other | Final Rejection | 17d overdue | Pending | Apr 03, 2020 |
| 16379763 | IMMORTALIZATION OF CELLS INCLUDING NEURONAL CELLS | The Johns Hopkins University | DUTT, ADITI | 1675 | §103 | Non-Final OA | — | Pending | Apr 09, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial81.4% of resolved applications prosecuted by Fox Rothschild LLP - Jhu were allowed, across 10,880 applications in USPTO records.
3.36 office actions per allowed application on average.
31 pending office actions as of October 2026, for 5 clients, before 29 examiners in 22 art units.
